Notice2023-28510
Endocrine Disruptor Screening Program (EDSP); Near-Term Strategies for Implementation; Notice of Availability and Request for Comment; Extension of Comment Period; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 26, 2023
Issuing agencies
Environmental Protection Agency
Abstract
In the Federal Register of December 14, 2023, EPA announced the extension of the comment period established in a document that published in the Federal Register of October 27, 2023 that announced the availability of and solicited comment on near-term strategies to help the Agency meet its obligations and commitments under the Federal Food, Drug, and Cosmetic Act (FFDCA), which requires, that EPA screen for and protect against endocrine disrupting effects in humans. This document corrects the extended comment period date that published in the Federal Register of December 14, 2023, which inadvertently included the incorrect year.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 246 (Tuesday, December 26, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 246 (Tuesday, December 26, 2023)]
[Notices]
[Pages 88907-88908]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-28510]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2023-0474; FRL-11384-03-OCSPP]
Endocrine Disruptor Screening Program (EDSP); Near-Term
Strategies for Implementation; Notice of Availability and Request for
Comment; Extension of Comment Period; Correction
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: In the Federal Register of December 14, 2023, EPA announced
the extension of the comment period established in a document that
published in the Federal Register of October 27, 2023 that announced
the availability of and solicited comment on near-term strategies to
help the Agency meet its obligations and commitments under the Federal
Food, Drug, and Cosmetic Act (FFDCA), which requires, that EPA screen
for and protect against endocrine disrupting effects in humans. This
document corrects the extended comment period date that published in
the Federal Register of December 14,
[[Page 88908]]
2023, which inadvertently included the incorrect year.
DATES: December 26, 2023.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2023-0474, through the Federal eRulemaking
Portal at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Follow the online instructions
for submitting comments. Do not submit electronically any information
you consider to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute. Additional
instructions on commenting and visiting the docket, along with more
information about dockets generally, is available at <a href="https://www.epa.gov/dockets">https://www.epa.gov/dockets</a>.
FOR FURTHER INFORMATION CONTACT: Catherine Aubee, Endocrine Disruptor
Screening Program (7505T), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; main telephone number: (202) 566-1030; email address:
<a href="/cdn-cgi/l/email-protection#79091c0a0d101a101d1c080c1c0a0d1016170a391c0918571e160f"><span class="__cf_email__" data-cfemail="ea9a8f999e8389838e8f9b9f8f999e83858499aa8f9a8bc48d859c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: To give stakeholders additional time to
review materials and prepare comments, EPA extended the comment period
established in the Federal Register document of October 27, 2023, at 88
FR 73841 (FRL-11384-01-OCSPP) for 60 days, from December 26, 2023.
However, the extended comment period date established in the Federal
Register document of December 14, 2023, at 88 FR 86644 (FRL-11384-02-
OCSPP), was incorrectly stated as February 26, 2023. This notice
corrects the comment period date to February 26, 2024. More information
on the action can be found in the Federal Register of October 27, 2023.
Correction
In the Federal Register of December 14, 2023, in FR Doc. 2023-
27405, on page 86644, in the first column, correct the Dates caption to
read:
DATES: The comment period for the document published in the Federal
Register of October 27, 2023, at 88 FR 73841 (FRL-11384-01-OCSPP) is
extended. Comments must be received on or before February 26, 2024.
Authority: 7 U.S.C. 136 et seq. and 21 U.S.C. 346a.
Dated: December 20, 2023.
Angela Hofmann,
Director, Regulatory Support Branch, Mission Support Division, Office
of Program Support, Office of Chemical Safety and Pollution Prevention.
[FR Doc. 2023-28510 Filed 12-22-23; 8:45 am]
BILLING CODE 6560-50-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 26, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.